EP3053597A4 - Agent a pour dialyse solide contenant un diacétate de métal alcalin, et agent de dialyse en deux parties de type à faible teneur en acétate l'utilisant - Google Patents

Agent a pour dialyse solide contenant un diacétate de métal alcalin, et agent de dialyse en deux parties de type à faible teneur en acétate l'utilisant Download PDF

Info

Publication number
EP3053597A4
EP3053597A4 EP14850601.7A EP14850601A EP3053597A4 EP 3053597 A4 EP3053597 A4 EP 3053597A4 EP 14850601 A EP14850601 A EP 14850601A EP 3053597 A4 EP3053597 A4 EP 3053597A4
Authority
EP
European Patent Office
Prior art keywords
dialysis
agent
alkali metal
same
type low
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP14850601.7A
Other languages
German (de)
English (en)
Other versions
EP3053597B1 (fr
EP3053597A1 (fr
Inventor
Michiko Myose
Hiroshi Noguchi
Junya Kikuishi
Hideyuki Aoyama
Mina HASHIMOTO
Yusuke Yoshimoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tomita Pharmaceutical Co Ltd
Original Assignee
Tomita Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tomita Pharmaceutical Co Ltd filed Critical Tomita Pharmaceutical Co Ltd
Publication of EP3053597A1 publication Critical patent/EP3053597A1/fr
Publication of EP3053597A4 publication Critical patent/EP3053597A4/fr
Application granted granted Critical
Publication of EP3053597B1 publication Critical patent/EP3053597B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1654—Dialysates therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Inorganic Chemistry (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Biochemistry (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • External Artificial Organs (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
EP14850601.7A 2013-10-02 2014-10-02 Agent a pour dialyse solide contenant un diacétate de métal alcalin, et agent de dialyse en deux parties de type à faible teneur en acétate l'utilisant Active EP3053597B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2013207381A JP5517321B1 (ja) 2013-10-02 2013-10-02 二酢酸アルカリ金属塩を含む固形透析用ａ剤、及びそれを用いた２剤型の低酢酸透析用剤
PCT/JP2014/076372 WO2015050188A1 (fr) 2013-10-02 2014-10-02 Agent a pour dialyse solide contenant un diacétate de métal alcalin, et agent de dialyse en deux parties de type à faible teneur en acétate l'utilisant

Publications (3)

Publication Number Publication Date
EP3053597A1 EP3053597A1 (fr) 2016-08-10
EP3053597A4 true EP3053597A4 (fr) 2017-05-24
EP3053597B1 EP3053597B1 (fr) 2020-11-25

Family

ID=51031257

Family Applications (1)

Application Number Title Priority Date Filing Date
EP14850601.7A Active EP3053597B1 (fr) 2013-10-02 2014-10-02 Agent a pour dialyse solide contenant un diacétate de métal alcalin, et agent de dialyse en deux parties de type à faible teneur en acétate l'utilisant

Country Status (7)

Country Link
US (1) US10525078B2 (fr)
EP (1) EP3053597B1 (fr)
JP (1) JP5517321B1 (fr)
KR (1) KR102319863B1 (fr)
PH (1) PH12016500572B1 (fr)
SG (1) SG11201602532XA (fr)
WO (1) WO2015050188A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015072494A1 (fr) 2013-11-12 2015-05-21 扶桑薬品工業株式会社 Nouveau cristal de diacétate de sodium et préparation de dialyse solide comprenant ledit cristal
CN105434460A (zh) * 2015-12-09 2016-03-30 广州骐骥生物科技有限公司 一种医用纯碳酸氢钠透析干粉
CH712274B1 (fr) * 2016-03-18 2020-06-30 Hemo Plus Sarl Unité pour la préparation d'au moins une solution de concentrés pour hémodialyse et procédé de préparation de cette solution.
EP3725286A1 (fr) * 2019-04-18 2020-10-21 B. Braun Melsungen AG Produit médical comprenant un récipient et un liquide aqueux contenant du bicarbonate
CN113155569B (zh) * 2021-04-21 2021-12-03 中国计量科学研究院 一种水产品中重金属元素含量现场检测方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10259133A (ja) * 1997-03-14 1998-09-29 Nikkiso Co Ltd 粒状の透析用剤およびその製造法
JP3433979B2 (ja) * 1993-08-24 2003-08-04 日機装株式会社 透析用剤及びその製造方法
WO2015050189A1 (fr) * 2013-10-02 2015-04-09 富田製薬株式会社 Agent de dialyse du type à trois composants contenant de l'acide acétique et un sel d'acide acétique
EP3070075A1 (fr) * 2013-11-12 2016-09-21 Fuso Pharmaceutical Industries, Ltd. Nouveau cristal de diacétate de sodium et préparation de dialyse solide comprenant ledit cristal

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4756838A (en) 1980-02-21 1988-07-12 Veltman Preston Leonard Preparation of dry dialysate products
US4655941A (en) 1984-02-13 1987-04-07 Tomita Pharmaceutical Corp., Ltd. Method of preparing mixed electrolyte powder for bicarbonate dialysis and powder mixture formed
US5091094A (en) 1985-06-24 1992-02-25 Veech Richard L Hemodialysis processes & hemodialysis solutions
AU627309B2 (en) 1989-05-26 1992-08-20 Terumo Kabushiki Kaisha Preparation for blood dialysis and method for production thereof
US5252213A (en) 1989-06-20 1993-10-12 University Of Washington Dry dialysate composition
FR2687307B1 (fr) 1992-02-14 1999-06-04 Lascombes Jean Jacques Dispositif pour la preparation d'une solution a usage medical.
US5616248A (en) 1992-04-06 1997-04-01 Schal; Wilfried Method for the preparation of hemodialysis fluids containing bicarbonate
DE668793T1 (de) 1992-11-12 1999-02-25 Althin Medical Inc., Miami Lakes, Fla. Methode zur vorrichtung zur nierendialyse.
JP2769592B2 (ja) 1992-12-14 1998-06-25 富田製薬株式会社 重炭酸透析用人工腎臓灌流用剤の製造方法及び人工腎臓灌流用剤
DK0633013T3 (da) * 1993-01-22 1999-01-18 Otsuka Pharma Co Ltd Opbevaringsbeholder til hydrogencarbonatholdigt pulverformigt medikament og fremgangsmåde til stabilisering af et sådant me
ATE196602T1 (de) 1993-02-19 2000-10-15 Schael Wilfried Verfahren zur bereitung von bicarbonathaltigen dialysierflüssigkeiten für die hämodialyse
JP2809971B2 (ja) 1993-07-06 1998-10-15 扶桑薬品工業株式会社 血液透析用製剤
JP3619921B2 (ja) 1996-09-13 2005-02-16 富田製薬株式会社 重炭酸固形透析用剤
US6399110B1 (en) 1997-08-22 2002-06-04 Shimizu Pharmaceutical Co., Ltd. Glucose-containing preparation
SE520638C2 (sv) 1998-01-21 2003-08-05 Gambro Lundia Ab Säkerhetsanordning vid dialysmaskin
US6489301B1 (en) * 1999-06-07 2002-12-03 Nipro Corporation Solid pharmaceutical preparation for dialysis and a process for producing the same
US6309673B1 (en) 1999-09-10 2001-10-30 Baxter International Inc. Bicarbonate-based solution in two parts for peritoneal dialysis or substitution in continuous renal replacement therapy
JP5204359B2 (ja) 2001-09-28 2013-06-05 味の素株式会社 透析用剤およびその製造方法
WO2004067014A1 (fr) 2003-01-31 2004-08-12 Manac Inc. Preparation solide destinee a la dialyse et procede de fabrication correspondant
WO2004066977A1 (fr) 2003-01-31 2004-08-12 Manac Inc. Agent solide utilise pour la dialyse et procede de production de ce dernier
CN1189180C (zh) * 2003-04-30 2005-02-16 广州康盛生物科技有限公司 一种碳酸氢盐血液透析干粉组合物
JPWO2005094918A1 (ja) 2004-03-30 2008-02-14 ニプロ株式会社 透析用固形製剤
JP2007130165A (ja) 2005-11-09 2007-05-31 Manac Inc 無臭透析用固形剤及びその製造方法
WO2010112570A1 (fr) 2009-03-31 2010-10-07 Gambro Lundia Ab Solution de dialyse
CA2803458C (fr) * 2010-06-23 2018-02-13 Gambro Lundia Ab Composition precurseur de dialyse
JP5099464B1 (ja) * 2011-12-29 2012-12-19 富田製薬株式会社 重炭酸イオン濃度可変型の透析液の調製装置及び調製方法、重炭酸イオン濃度可変型の透析剤、並びに重炭酸イオン濃度可変型の透析システム
JP5376480B1 (ja) * 2012-10-10 2013-12-25 富田製薬株式会社 酢酸及び酢酸塩を含む透析用ａ剤、及びそれを用いた２剤型透析用剤

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3433979B2 (ja) * 1993-08-24 2003-08-04 日機装株式会社 透析用剤及びその製造方法
JPH10259133A (ja) * 1997-03-14 1998-09-29 Nikkiso Co Ltd 粒状の透析用剤およびその製造法
WO2015050189A1 (fr) * 2013-10-02 2015-04-09 富田製薬株式会社 Agent de dialyse du type à trois composants contenant de l'acide acétique et un sel d'acide acétique
EP3070075A1 (fr) * 2013-11-12 2016-09-21 Fuso Pharmaceutical Industries, Ltd. Nouveau cristal de diacétate de sodium et préparation de dialyse solide comprenant ledit cristal

Also Published As

Publication number Publication date
JP2015071557A (ja) 2015-04-16
KR20160064182A (ko) 2016-06-07
EP3053597B1 (fr) 2020-11-25
PH12016500572A1 (en) 2016-06-20
EP3053597A1 (fr) 2016-08-10
PH12016500572B1 (en) 2016-06-20
KR102319863B1 (ko) 2021-10-29
JP5517321B1 (ja) 2014-06-11
US10525078B2 (en) 2020-01-07
SG11201602532XA (en) 2016-05-30
US20160235785A1 (en) 2016-08-18
WO2015050188A1 (fr) 2015-04-09

Similar Documents

Publication Publication Date Title
EP3028100A4 (fr) Système et procédé de projection bimodal spécifiques à une application
EP3064534A4 (fr) Film de cellulose régénérée, film fonctionnel et procédé de préparation associé
EP3036938A4 (fr) Mise en réseau définie par logiciel mobile (mobisdn)
EP3029035A4 (fr) Composé de tétrazolinone et utilisation s'y rapportant
EP3082619A4 (fr) Occlusion vasculaire
EP3079621A4 (fr) Ensemble cathéter et manche, systèmes et procédés
EP3053116A4 (fr) Activation de synchronisation entre des systèmes de compte de paiement disparates
EP3016624A4 (fr) Composite absorbant, article absorbant l'utilisant, et procédés, systèmes et appareil pour la fabrication du composite et/ou de l'article absorbant
EP3020446A4 (fr) Raccord pour liquide, et seringue
EP2938252A4 (fr) Dispositifs intravasculaires, systèmes, et procédés associés
EP3034085A4 (fr) Médicament contenant du chitosane cationisé
EP2994042A4 (fr) Dispositifs, systèmes et procédés permettant de mesurer une perte de sang
EP2866872A4 (fr) Dispositifs intravasculaires, systèmes et procédés
EP2873588B8 (fr) Poussette
EP3071295A4 (fr) Procédés, compositions et dispositifs anti-infectieux
EP3057496A4 (fr) Dispositifs, systèmes et procédés intravasculaires
EP3022113A4 (fr) Système, composants, procédés et applications de surveillance
EP2988845A4 (fr) Systèmes, éléments, et procédés de filtration de liquide
EP3029030A4 (fr) Composé tétrazolinone et son utilisation
EP3122459A4 (fr) Procedes et systemes pour former des ensembles catalytiques, et ensembles catalytiques associes
EP3081348A4 (fr) Préhenseur, robot et cellule robotisée
EP3073171A4 (fr) Film d'isolation thermique et structure de film d'isolation thermique
EP3081380A4 (fr) Système hydraulique à grande vitesse à circulation interne, plate-forme hydraulique, et ensemble plate-forme hydraulique
EP2985078A4 (fr) Composite contenant des nanoparticules métalliques catalytiques et son utilisation
EP3013145A4 (fr) Tétrahydrofurane-2,5-dicarbaldéhyde (diformyl-tétrahydrofurane, dfthf) et procédé de synthèse de celui-ci

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20160419

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20170424

RIC1 Information provided on ipc code assigned before grant

Ipc: A61M 1/14 20060101ALI20170418BHEP

Ipc: A61K 47/02 20060101ALI20170418BHEP

Ipc: A61P 7/08 20060101ALI20170418BHEP

Ipc: A61K 9/08 20060101ALI20170418BHEP

Ipc: A61K 47/26 20060101ALI20170418BHEP

Ipc: A61K 47/12 20060101AFI20170418BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20190103

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20200429

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 1337529

Country of ref document: AT

Kind code of ref document: T

Effective date: 20201215

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602014072771

Country of ref document: DE

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 1337529

Country of ref document: AT

Kind code of ref document: T

Effective date: 20201125

REG Reference to a national code

Ref country code: NL

Ref legal event code: MP

Effective date: 20201125

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210226

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210325

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210225

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201125

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201125

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201125

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210225

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201125

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201125

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210325

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201125

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG9D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201125

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201125

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201125

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201125

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201125

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201125

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201125

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602014072771

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201125

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201125

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201125

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201125

26N No opposition filed

Effective date: 20210826

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201125

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201125

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20210325

REG Reference to a national code

Ref country code: BE

Ref legal event code: MM

Effective date: 20211031

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201125

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20211002

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20211031

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20211031

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20211031

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20211002

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20141002

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201125

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20231023

Year of fee payment: 10

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20231027

Year of fee payment: 10

Ref country code: DE

Payment date: 20231027

Year of fee payment: 10

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201125

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20201125